Key result
Vagus nerve stimulation yields stroke treatment potential in animal models by improving neurological deficit score, infarct volume, forelimb strength, inflammation, apoptosis, and angiogenesis.
Why the study?
Reperfusion therapies for ischemic stroke can cause reperfusion injury, prompting evaluation of vagus nerve stimulation as an alternative therapeutic intervention.
Does vagus nerve stimulation improve neurological and histological outcomes in animal models of stroke-induced injury?
Systematic Review
Does vagus nerve stimulation improve neurological and histological outcomes in animal models of stroke-induced injury?
Vagus nerve stimulation demonstrates neuroprotective potential in animal models of ischemic stroke, supporting further translational research.
Supports vagus nerve stimulation in preclinical stroke models; leaves open translation to human trials.
Ischemic stroke is one of the leading causes of death worldwide, and poses a great burden to society and the healthcare system. There have been many recent advances in the treatment of ischemic stroke, which usually results from the interruption of blood flow to a particular part of the brain. Current treatments for ischemic stroke mainly focus on revascularization or reperfusion of cerebral blood flow to the infarcted tissue. Nevertheless, reperfusion injury may exacerbate ischemic injury in patients with stroke. In recent decades, vagus nerve stimulation (VNS) has emerged as an optimistic therapeutic intervention. Accumulating evidence has demonstrated that VNS is a promising treatment for ischemic stroke in various rat models through improved neural function, cognition, and neuronal deficit scores. We thoroughly examined previous evidence from stroke-induced animal studies using VNS as an intervention until June 2022. We concluded that VNS yields stroke treatment potential by improving neurological deficit score, infarct volume, forelimb strength, inflammation, apoptosis, and angiogenesis. This review also discusses potential molecular mechanisms underlying VNS-mediated neuroprotection. This review could help researchers conduct additional translational research on patients with stroke.
No takes yet. Share an insight, caveat, or question.
Hasan et al. (2023) conducted a systematic review in Ischemic stroke (animal models). Vagus nerve stimulation (VNS) was evaluated on Neurological deficit score, infarct volume, forelimb strength, inflammation, apoptosis, and angiogenesis. Vagus nerve stimulation yields stroke treatment potential in animal models by improving neurological deficit score, infarct volume, forelimb strength, inflammation, apoptosis, and angiogenesis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: